The Clinical Impacts and Risk Factors for Non-central Line-associated Bloodstream Infection in 5046 ICU Patients

ccforum.biomedcentral.com
the-clinical-impacts-and-risk-factors-for-non-central-line-associated-bloodstream-infection-in-5046-icu-patients

Most of the previous studies focused on central line-associated bloodstream infection (CLABSI), while non-central line-associated bloodstream infection (N-CLABSI) was poorly studied. This study was performed to investigate the clinical impacts and risk factors for N-CLABSI in intensive care unit (ICU) patients. N-CLABSI was associated with similar poor outcomes with CLABSI, including prolonged LOS in ICU and in hospital and increased hospitalization costs and predicted mortality in ICU. The risk factors for N-CLABSI identified in this study provide further insight in preventing N-CLABSI. Of 5046 patients included, 155 developed 168 ICU-acquired N-CLABSI episodes in the ICU, accounted for the majority of nosocomial bloodstream infections.

Read More